Mapping large numbers of results may take a few moments.
Search Results
Showing 251 - 300 of 328 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Pyramid Pharmaceutical Company LLC | Activity: Research and Development | Company Description Pyramid Pharmaceutical develops generic products and new technologies for drug delivery. | Location Wilmington | |
Company QuatroBio LLC | Activity: Research and Development | Company Description QuatroBio provides oversight and strategic direction to several closely held drug development companies. | Location Morrisville | |
Company Qura Therapeutics LLC | Activity: Research and Development | Company Description Qura Therapeutics is discovering therapeutics for curing HIV/AIDS. Qura is a joint venture between ViV Healthcare and UNC-CH and provides financial, material and development support for therapies that emerge from research at the UNC HIV Cure Center. | Location Chapel Hill | |
Company RainBio Inc. | Activity: Research and Development | Company Description RainBio is developing AAV (adeno-associated virus) gene therapy corneal treatments to address the unmet need of treatment of rare corneal blinding diseases. | Location Raleigh | |
Company Reactive Biosciences Inc. | Activity: Research and Development | Company Description Reactive Biosciences uses a boron-based discovery platform to discover and develop new medicines. | Location Durham | |
Company READDI Inc. | Activity: Research and Development | Company Description Rapidly Emerging Antiviral Drug Development Initiative (READDI) is a public-private partnership that develops broad-spectrum antiviral therapies for COVID-19 and other emerging viral threats. | Location Chapel Hill | |
Company RedHill Biopharma Inc. | Activity: Sales and Operations | Company Description RedHill Biopharma develops and commercializes orally-administered, small-molecule drugs for the treatment of gastrointestinal and inflammatory diseases, including cancer. Its Raleigh site is the company's U.S. commercial headquarters. | Location Raleigh | |
Company Regennova Inc. | Activity: Research and Development | Company Description Regennova develops therapeutics for inflammatory diseases and neurological disorders, including cerebral stroke, traumatic brain injury, Alzheimer's and sepsis. | Location Durham | |
Company Relevant Biosciences Inc. | Activity: Research and Development | Company Description Relevant Bio develops natural antibody-based cancer therapeutics. | Location Raleigh | |
Company Relion Inc. | Activity: Production and Manufacturing | Company Description Relion Manufacturing provides contract manufacturing and packaging services for the pharmaceutical, medical device and personal care industries. | Location Swannanoa | |
Company Renovion Inc. | Activity: Research and Development | Company Description Renovion is a clinical stage company developing therapies for chronic inflammatory lung diseases, including bronchiectasis, BOS in lung transplant and chronic bronchitis. | Location Chapel Hill | |
Company Resilience (Durham) | Activity: Production and Manufacturing | Company Description Resilience manufactures viral vectors, a component of cell and gene therapies. | Location Durham | |
Company Resilient Biotics Inc. | Activity: Research and Development | Company Description Resilient Biotics is developing non-antibiotic, microbiome-based therapeutics to combat complex respiratory infections with applications in human and animal health. Resilient utilizes a proprietary discovery platform for product development and has a broad pipeline across multiple species. | Location Durham | |
Company Resolian (Raleigh) | Activity: Sales and Operations | Company Description Resolian is a global contract research organization specializing in bioanalytics for small and large molecules, Drug Metabolism and Pharmacokinetics (DMPK) and analytical services supporting CMC. The Raleigh office is a commercial office. | Location Raleigh | |
Company Reveris Therapeutics LLC | Activity: Research and Development | Company Description Reveris Therapeutics develops novel therapeutics for triple negative breast cancer (TNBC). | Location Chapel Hill | |
Company Revivo Therapeutics Inc. | Activity: Research and Development | Company Description Revivo Therapeutics is a clinical stage company developing therapies for cognitive dysfunction and neuroprotection. | Location Durham | |
Company Ribometrix Inc. | Activity: Research and Development | Company Description Ribometrix is developing a new class of small-molecule therapeutics that directly target and modulate the function of RNA to treat human diseases. | Location Durham | |
Company Roivant Sciences Inc. | Activity: Research and Development | Company Description Roivant Sciences acquires drug candidates or partners with the biopharma industry to complete the clinical development of shelved product candidates. Therapeutic areas include neurology, dermatology, hepatology, oncology, endocrinology and rare disease. | Location Durham | |
Company RTT Medical | Activity: Research and Development | Company Description RTT Medical provides regenerative tissue technologies for wound management. | Location Winston-Salem | |
Company Sandoz Inc. (Wilson) | Activity: Production and Manufacturing | Company Description Sandoz develops generic and biosimilar medicines. Its facility in Wilson manufactures oral-dosage generic pharmaceuticals. | Location Wilson | |
Company Sarepta Therapeutics Inc. (Durham) | Activity: Research and Development | Company Description Sarepta Therapeutics develops precision genetic medicine treatments for Duchenne muscular dystrophy (DMD), Limb-girdle muscular dystrophy (LGMD) and other central nervous system (CNS) disorders. Sarepta's Gene Editing Innovation Center is in Durham. | Location Durham | |
Company Satsuma Pharmaceuticals Inc. | Activity: Research and Development | Company Description Satsuma Pharmaceuticals is developing best-in-class intranasal drug products to address the significant unmet medical needs of acute migraine sufferers. | Location Durham | |
Company SCN BestCo Inc. | Activity: Production and Manufacturing | Company Description SCN BestCo manufactures over-the-counter drugs and dietary supplements and offers contract product manufacturing and packaging. | Location Mooresville | |
Company Shattuck Labs Inc. | Activity: Research and Development | Company Description Shattuck Labs is a preclinical-stage immunotherapy company focused on utilizing its proprietary ARC (Agonist Redirected Checkpoint) technology to develop novel treatments for use in cancer, inflammation and orphan disease. | Location Durham | |
Company SIF Biopharma LLC | Activity: Research and Development | Company Description SIF Biopharma develops new therapies in the areas of regenerative medicine and cancer. | Location Chapel Hill | |
Company Sobi (Durham) | Activity: Research and Development | Company Description Sobi develops treatments for orphan diseases with a focus on inflammation and genetic diseases. | Location Durham | |
Company Solve Therapeutics Inc. | Activity: Research and Development | Company Description Solve Therapeutics develops antibody-drug conjugates (ADC) and antibody-radionuclide conjugates (ARC) for oncology patients. | Location Durham | |
Company SoyMeds Inc. | Activity: Research and Development | Company Description SoyMeds uses soybeans as a host to develop protein-based targets that can be used to diagnose and treat disease. SoyMeds' lead candidates include thyroglobulin and autoimmune (MS and MG) antigens. | Location Charlotte | |
Company SpringWorks Therapeutics LLC | Activity: Research and Development | Company Description SpringWorks Therapeutics develops standalone and combination therapies with a focus on rare diseases and oncology, including plexiform neurofibroma, desmoid tumors, RAS/RAF mutant solid tumors and CNS disorders. Its initial portfolio is from Pfizer. | Location Durham | |
Company Sprout Pharmaceuticals Inc. | Activity: Sales and Operations | Company Description Sprout Pharmaceuticals has developed and markets a compound to treat hypoactive sexual desire disorder in women who have not gone through menopause. | Location Raleigh | |
Company SPV Therapeutics Inc. | Activity: Research and Development | Company Description SPV Therapeutics is developing small molecule therapeutics to treat cancer. | Location Research Triangle Park | |
Company Stallergenes Greer | Activity: Production and Manufacturing | Company Description Stallergenes Greer develops and distributes animal and human allergy immunotherapy products and services. | Location Lenoir | |
Company Sumitomo Pharma America Inc. (Cary) | Activity: Research and Development | Company Description Sumitomo Pharma America develops regenerative therapeutics for rare diseases such as congenital athymia. | Location Cary | |
Company Symberix Inc. | Activity: Research and Development | Company Description Symberix is developing microbiome-targeted, small-molecule drugs to treat serious lower gastrointestinal (GI) diseases such as Inflammatory Bowel Disorder (IBD) as well as mitigate the lower GI side effects associated with various pain, cancer and immunosuppressive therapies. | Location Durham | |
Company Synoxa Sciences Inc. | Activity: Research and Development | Company Description Synoxa Sciences develops small molecule therapeutics to treat multi-drug resistant (MDR) bacterial pathogens, including those in the biofilm state. | Location Raleigh | |
Company Synthon Pharmaceuticals Inc. | Activity: Sales and Operations | Company Description Synthon Pharmaceuticals develops and manufactures generics, as well as specialty pharmaceuticals and biosimilars in key therapeutic areas of oncology and multiple sclerosis. The Durham location is a regulatory office. | Location Research Triangle Park | |
Company T3D Therapeutics Inc. | Activity: Research and Development | Company Description T3D Therapeutics is developing a disease-modifying drug therapy for Alzheimer’s disease that may improve multiple disease defects. T3D is also targeting treatments for other neurodegenerative diseases including Huntington's Disease. | Location Research Triangle Park | |
Company Takeda Vaccines Inc. | Activity: Sales and Operations | Company Description Takeda's Vaccine Business Unit develops vaccines, including norovirus, dengue and seasonal influenza candidate vaccines. | Location Morrisville | |
Company TARGAN Inc. | Activity: Research and Development | Company Description TARGAN is developing automated bio-system solutions for detecting, targeting, and delivering vaccines for the animal health industry. TARGAN's technologies aim to reduce the need for antibiotics by improving vaccination delivery. | Location Raleigh | |
Company Tavros Therapeutics Inc. | Activity: Research and Development | Company Description Tavros is developing first-in-class therapeutics for cancer by using a novel precision oncology platform. | Location Research Triangle Park | |
Company Taysha Gene Therapies Inc. | Activity: Production and Manufacturing | Company Description Taysha Gene Therapies develops and manufactures gene therapies for the treatment of monogenic diseases of the central nervous system (CNS), both in rare and large patient populations. | Location Research Triangle Park | |
Company TCRCure Biopharma Corp. | Activity: Research and Development | Company Description TCRCure Biopharma discovers and develops novel therapeutic targets in the field of cancer immunotherapy. | Location Durham | |
Company Tellus Therapeutics Inc. | Activity: Research and Development | Company Description Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. | Location Research Triangle Park | |
Company Ten63 Therapeutics Inc. | Activity: Research and Development | Company Description Ten63 Therapeutics uses computational chemistry and AI to screen trillions of molecules to discover new therapeutics for a wide variety of diseases. | Location Durham | |
Company Tenax Therapeutics Inc. | Activity: Research and Development | Company Description Tenax Therapeutics develops and commercializes pharmaceutical products for the critical care market. | Location Morrisville | |
Company Tergus Pharma LLC | Activity: Production and Manufacturing | Company Description Tergus Pharma provides contract services for topical pharmaceuticals, including research, drug development, and testing to scale-up and commercial manufacturing. | Location Durham | |
Company TG Therapeutics Inc. | Activity: Research and Development | Company Description TG Therapeutics is a commercial stage biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. | Location Morrisville | |
Company TheraSplice | Activity: Research and Development | Company Description TheraSplice is developing a precision oncology platform and products. The company has several targets under development in prostate, lung, breast, and liver cancer with the goal of initiating biomarker stratified clinical trials. | Location Chapel Hill | |
Company TheraVida Inc. | Activity: Research and Development | Company Description TheraVida is developing a treatment for primary focal hyperhidrosis. | Location Chapel Hill | |
Company Thermo Fisher Scientific (Durham) | Activity: Contract Research and Testing | Company Description Thermo Fisher’s Pharma Services Division offers drug development and manufacturing. The Durham site provides contract development and manufacturing services for solid and sterile dosage forms, including small-molecule API and biologic drug substances. | Location Durham |